Alexandria Real Estate Equities ARE will host investors at the recently completed and over 90%
leased/committed first building (310,000 sf) at its Alexandria Center for Life Science project in Manhattan.
Keefe Bruyette & Woods believes ARE shares should be poised once again to outperform in December - similar to 2009. The ARE analyst day should boost awareness of ARE's positive growth outlook, its niche expertise, and franchise value from its focused cluster market strategy.
Keefe Bruyette & Woods has an Outperform rating and $79 PT on ARE
ARE closed Tuesday at $69.31
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in